[go: up one dir, main page]

AUPS295802A0 - Metallothionein based neuronal therapeutic and therapeutic methods - Google Patents

Metallothionein based neuronal therapeutic and therapeutic methods

Info

Publication number
AUPS295802A0
AUPS295802A0 AUPS2958A AUPS295802A AUPS295802A0 AU PS295802 A0 AUPS295802 A0 AU PS295802A0 AU PS2958 A AUPS2958 A AU PS2958A AU PS295802 A AUPS295802 A AU PS295802A AU PS295802 A0 AUPS295802 A0 AU PS295802A0
Authority
AU
Australia
Prior art keywords
therapeutic
metallothionein
methods
based neuronal
therapeutic methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPS2958A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tasmania
Original Assignee
University of Tasmania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tasmania filed Critical University of Tasmania
Priority to AUPS2958A priority Critical patent/AUPS295802A0/en
Publication of AUPS295802A0 publication Critical patent/AUPS295802A0/en
Priority to AU2003233259A priority patent/AU2003233259B2/en
Priority to US10/517,653 priority patent/US8691765B2/en
Priority to PCT/AU2003/000735 priority patent/WO2003105910A1/en
Priority to EP03727024A priority patent/EP1531905A4/en
Priority to NZ537103A priority patent/NZ537103A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPS2958A 2002-06-13 2002-06-13 Metallothionein based neuronal therapeutic and therapeutic methods Abandoned AUPS295802A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPS2958A AUPS295802A0 (en) 2002-06-13 2002-06-13 Metallothionein based neuronal therapeutic and therapeutic methods
AU2003233259A AU2003233259B2 (en) 2002-06-13 2003-06-13 Metallothionein based neuronal therapeutic and therapeutic methods
US10/517,653 US8691765B2 (en) 2002-06-13 2003-06-13 Metallothionein based neuronal therapeutic and therapeutic methods
PCT/AU2003/000735 WO2003105910A1 (en) 2002-06-13 2003-06-13 Metallothionein based neuronal therapeutic and therapeutic methods
EP03727024A EP1531905A4 (en) 2002-06-13 2003-06-13 NEURONAL THERAPEUTIC PRODUCT BASED ON METALLOTHIONEIN AND THERAPEUTIC METHODS
NZ537103A NZ537103A (en) 2002-06-13 2003-06-13 Metallothionein based neuronal therapeutic and therapeutic methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPS2958A AUPS295802A0 (en) 2002-06-13 2002-06-13 Metallothionein based neuronal therapeutic and therapeutic methods

Publications (1)

Publication Number Publication Date
AUPS295802A0 true AUPS295802A0 (en) 2002-07-04

Family

ID=3836520

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPS2958A Abandoned AUPS295802A0 (en) 2002-06-13 2002-06-13 Metallothionein based neuronal therapeutic and therapeutic methods

Country Status (4)

Country Link
EP (1) EP1531905A4 (en)
AU (1) AUPS295802A0 (en)
NZ (1) NZ537103A (en)
WO (1) WO2003105910A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2412726B1 (en) 2006-02-14 2016-06-15 University Of Tasmania Through The Menzies Research Institute Metallothionein-derived peptide fragments
WO2007110079A2 (en) * 2006-03-29 2007-10-04 Enkam Pharmaceuticals A/S Targeted delivery of fgfr ligands into the brain
CN106552258A (en) * 2016-02-15 2017-04-05 聊城市奥润生物医药科技有限公司 Zn7Applications of the MT3 in preventing and treating Alzheimer's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5431923A (en) * 1992-02-17 1995-07-11 Indena S.P.A. Topical cosmetic and/or pharmaceutical compositions
GB9203299D0 (en) * 1992-02-17 1992-04-01 Indena Spa Cosmetic and/or pharmaceutical compositions and methods for their use
US5814480A (en) * 1997-01-17 1998-09-29 Incyte Pharmacueticals, Inc. DNA encoding human metallothioein
ES2198171B1 (en) * 2000-09-06 2005-04-16 Provital, S.A. COSMETIC AND / OR PHARMACEUTICAL COMPOSITION CONTAINING METALOTIONEINE.
US20020155170A1 (en) * 2000-11-30 2002-10-24 Walsh William John Nutrient supplements and methods for treating autism and for preventing the onset of autism

Also Published As

Publication number Publication date
NZ537103A (en) 2007-11-30
EP1531905A1 (en) 2005-05-25
EP1531905A4 (en) 2010-12-22
WO2003105910A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
AU2003283257A1 (en) Scalp treatment
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU2003257702A1 (en) Optometric device and optometric method
GB0223367D0 (en) Therapeutic treatment
AU2003249722A1 (en) Therapeutic amides
AU2002357267A1 (en) Immune related neuronal receptors and therapeutic uses thereof
HK1078784A1 (en) Therapeutic treatment
GB0207410D0 (en) Compounds and their therapeutic use
GB0308382D0 (en) Therapeutic methods and means
GB0210464D0 (en) Therapeutic treatment
AU2003302323A1 (en) A method and therapeutic platelets
AU2003247367A1 (en) Stimulation and injection system
AUPS295802A0 (en) Metallothionein based neuronal therapeutic and therapeutic methods
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
EP1569928A4 (en) Therapeutic compounds and methods
AU2003304289A1 (en) A method and therapeutic platelets
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003231937A1 (en) Therapeutic methods
AU2003245674A1 (en) Oral disease prevention and treatment
GB0205826D0 (en) Therapeutic compositions and methods
GB0230138D0 (en) Methods and therapeutic treatments
AU2003287840A1 (en) Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses
AU2002952657A0 (en) Therapeutic agents and uses therefor-II